Jakarta –
The frenzy of Corona virus infection in China makes it difficult for residents to get access to medicine for the disease. Not to mention, the country limits imports of drugs and vaccines from abroad for handling COVID-19.
reported Reuters, so far China has relied on domestically made vaccines and drugs to fight the pandemic. Pfizer’s COVID-19 anti-viral drug (PFE.N) Paxlovid is available in China but is very difficult to obtain through official channels.
Molnupiravir, which is also relied on as a COVID-19 drug, is not free to use even though it has been approved by the Chinese government.
Xi Jinping’s administration has provided no data on how much treatment is provided and where the COVID drug can be purchased, forcing most patients to rely on media reports, word of mouth or even importing through unofficial channels on the black market.
Those who manage to find suppliers often end up paying exorbitant prices, as demand soars amid the giant waves of COVID-19 infections.
Next: the price of COVID-19 medicine is expensive
